Get started
Reneuron Group Plc.Reneuron Group Plc.Reneuron Group Plc.

Reneuron Group Plc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

RNUGF chart

Upcoming earnings

Next report date
Report period
H2 2023
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪2.41 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1082USD
Net income (FY)
‪−6.67 M‬USD
Revenue (FY)
‪653.65 K‬USD
Shares float
‪48.94 M‬
Beta (1Y)
−0.73

About RENEURON GROUP ORD GBP0.01

Sector
Health Technology
Headquarters
Pencoed
Employees (FY)
26
Website
reneuron.com
Founded
2005
ISIN
GB00BF5G6K95
FIGI
BBG000NSZ3T6
ReNeuron Group Plc engages in the development of novel cell-based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RNUGF is 0.0011 USD — it has decreased by 97.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Reneuron Group Plc. stocks are traded under the ticker RNUGF.
Reneuron Group Plc. is going to release the next earnings report on Jul 11, 2024. Keep track of upcoming events with our Earnings Calendar.
RNUGF stock is ‪3.76 K‬% volatile and has beta coefficient of −0.73. Check out the list of the most volatile stocks — is Reneuron Group Plc. there?
RNUGF earnings for the last quarter are −0.28 USD per share, whereas the estimation was −0.34 USD resulting in a 15.36% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about Reneuron Group Plc. earnings.
Reneuron Group Plc. revenue for the last quarter amounts to ‪124.00 K‬ USD despite the estimated figure of ‪2.17 M‬ USD. In the next quarter revenue is expected to reach ‪1.38 M‬ USD.
Yes, you can track Reneuron Group Plc. financials in yearly and quarterly reports right on TradingView.
RNUGF net income for the last quarter is ‪−3.47 M‬ USD, while the quarter before that showed ‪−2.75 M‬ USD of net income which accounts for −25.88% change. Track more Reneuron Group Plc. financial stats to get the full picture.
Today Reneuron Group Plc. has the market capitalization of ‪2.41 M‬, it has increased by 0.21% over the last week.
No, RNUGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RNUGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Reneuron Group Plc. stock right from TradingView charts — choose your broker and connect to your account.
RNUGF reached its all-time high on Apr 29, 2019 with the price of 4.4300 USD, and its all-time low was 0.0011 USD and was reached on Apr 10, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 26.00 employees. See our rating of the largest employees — is Reneuron Group Plc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Reneuron Group Plc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Reneuron Group Plc. stock shows the sell signal. See more of Reneuron Group Plc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Reneuron Group Plc. EBITDA is ‪−7.17 M‬ USD, and current EBITDA margin is ‪−1.29 K‬%. See more stats in Reneuron Group Plc. financial statements.